![Carmine Stengone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 282 742 $ in data 31/08/2026
Mr. Carmine N.
Stengone is an Independent Director at Kiora Pharmaceuticals, Inc. and a President, Chief Executive Officer & Director at Contineum Therapeutics, Inc. He is on the Board of Directors at Kiora Pharmaceuticals, Inc. and Contineum Therapeutics, Inc. Mr. Stengone was previously employed as a Senior Vice President-Business Development by COI Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Avelas Biosciences, Inc., a President, Chief Executive Officer & Director by Afraxis, Inc., a Senior Director-Business Development by Phenomix Corp., a Senior Manager-Strategic Marketing by Anadys Pharmaceuticals, Inc., and a Principal by Johnson & Johnson Pharmaceutical Research & Development LLC.
He received his undergraduate degree from Wake Forest University, a graduate degree from Duke University and an MBA from Johnson Graduate School of Management.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/09/2026 | 17.217 ( 0,05% ) | 279 604 $ | 31/08/2026 | |
| 10/06/2026 | 1.250 ( 0,03% ) | 3 138 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Amministratore Delegato | 01/10/2018 |
| KIORA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/08/2023 |
| Società | Posizione | Fine |
|---|---|---|
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Amministratore Delegato | 01/01/2018 |
COI Pharmaceuticals, Inc.
 COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Corporate Officer/Principal | 01/10/2018 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 28/10/2010 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Vendite & Marketing | 01/01/2006 |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Corporate Officer/Principal | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Kiora Pharmaceuticals, Inc.
 Kiora Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases | Health Technology |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson & Johnson Pharmaceutical Research & Development LLC
Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services | Commercial Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
COI Pharmaceuticals, Inc.
COI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides life science inventors with an environment where entrepreneurial and scientific risks are encouraged and rewarded | Health Technology |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
